Log in

Login to your account

Password *
Remember Me

PAD-IQ Logo 2013

  • Supports Non-Invasive Upper and Lower Extremity Vascular Assessments
    • Skin Perfusion Pressure – Microcirculation (segmental pressure assessments with reactive hyperemia)
    • Pulse Volume Recording (segmental volume plethysmography)
    • Ankle Brachial Index (ABI) Calculation for Doppler-obtained pressures

Vasamed Supports Telemedicine

SensiLase PAD-IQ can go wherever you treat patients; a ruggedized, customized roller bag keeps the product safe and has ample room for supplies. SensiLase PAD-IQ features access to the internet via Bluetooth, WiFi or Ethernet while Studycast permits you to log-in from anywhere to upload data and images for expert consult and secure data storage.

Read More

Are you using your “IQ” to test for PAD and CLI?

Väsamed’s SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals numerous support tools for both PAD and CLI to enable noninvasive vascular diagnostics, data communication and management. Read more about tissue perfusion, reactive hyperemia, volume plethysmography and wound imaging here.

Read More


Who is at risk for P.A.D?

Patients over age 50 and who also have a history of diabetes or history of smoking are at risk of PAD. Even patients under age 50 but who have diabetes and risk factors such as obesity, high blood pressure, a history of non-healing ulcers, erectile dysfunction (ED) or kidney disease (CKD/ESRD) are at risk. Consult your doctor if you exhibit these risk-factors.

Read More

Latest News

  • A Guide To Microvascular Assessment For Wound Healing
    Written by
    The May edition of Podiatry Today includes an article, "A Guide To Microvascular Assessment For Wound Healing" which addresses the importance of performing microcirculatory assessments in wound care.   The authors provide a detailed overview of available non-invasive vascular testing methods and conclude that traditional macrocirculatory diagnostic tests such as…
    Written on Thursday, 21 May 2015 14:37 in Vasamed News
  • SensiLase PAD-IQ Receives CE Mark Approval
    Written by
    Väsamed, Inc., a Minnesota-based medical device company, announced today that it received CE Mark approval to market its SensiLase PAD-IQ® System for the diagnostic assessment of peripheral tissue perfusion using SPP and PVR in Europe. PAD-IQ’s approval was supported by years of quality and compelling efficacy data published by leading…
    Written on Monday, 18 May 2015 19:32 in Vasamed News
  • Korean Foot and Ankle Society, 2015, Diabetic Foot Symposium
    Written by
    Thank you for visiting our booth at Korean Foot and Ankle Society, 2015, Diabetic Foot Symposium, last week. Pictured from left to right are PAD-IQ market, sales and product managers, Mr. Gene Lee, Ms. Hyun Jin Yeo, and Mr. Tae Hoon Yoon.
    Written on Monday, 18 May 2015 18:52 in Vasamed News
  • First day #SAWC
    Written by
    First day #SAWC and VÄSAMED Booth 850 is packed with wound specialists learning about angiosome guided SPP. 
    Written on Friday, 01 May 2015 16:28 in Vasamed News
  • #SAWC/WHS Spring 2015
    Written by
    #SAWC/WHS Spring 2015 Väsamed Inc. Booth 850, Conversation with Authors, Fri, May 1 at 7:15PM Meet Audrey Moyer-Harris BSN RN CWCN MBA Utilization Advanced Tech for Screening and Treating PAD: Healing Wounds and Preventing Amputations. Ms. Moyer-Harris will also be at Väsamed’s Booth on Friday and Saturday to discuss her work in PAD…
    Written on Thursday, 30 April 2015 13:19 in Vasamed News

Upcoming Events